| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |